146 related articles for article (PubMed ID: 2447225)
1. Fusion proteins with multiple copies of the major antigenic determinant of foot-and-mouth disease virus protect both the natural host and laboratory animals.
Broekhuijsen MP; van Rijn JM; Blom AJ; Pouwels PH; Enger-Valk BE; Brown F; Francis MJ
J Gen Virol; 1987 Dec; 68 ( Pt 12)():3137-43. PubMed ID: 2447225
[TBL] [Abstract][Full Text] [Related]
2. Recombinant fusion protein and DNA vaccines against foot and mouth disease virus infection in guinea pig and swine.
Huang H; Yang Z; Xu Q; Sheng Z; Xie Y; Yan W; You Y; Sun L; Zheng Z
Viral Immunol; 1999; 12(1):1-8. PubMed ID: 10333237
[TBL] [Abstract][Full Text] [Related]
3. Comparison of immune responses against foot-and-mouth disease virus induced by fusion proteins using the swine IgG heavy chain constant region or beta-galactosidase as a carrier of immunogenic epitopes.
Li G; Chen W; Yan W; Zhao K; Liu M; Zhang J; Fei L; Xu Q; Sheng Z; Lu Y; Zheng Z
Virology; 2004 Oct; 328(2):274-81. PubMed ID: 15464847
[TBL] [Abstract][Full Text] [Related]
4. Protection of cattle and swine against foot-and-mouth disease, using biosynthetic peptide vaccines.
Morgan DO; Moore DM
Am J Vet Res; 1990 Jan; 51(1):40-5. PubMed ID: 2154148
[TBL] [Abstract][Full Text] [Related]
5. Protection conferred by TrpE fusion proteins containing portions of the C-terminal region of capsid protein VP1 of foot-and-mouth disease virus.
Giavedoni LD; Kaplan G; Marcovecchio F; Piccone ME; Palma EL
J Gen Virol; 1991 Apr; 72 ( Pt 4)():967-71. PubMed ID: 1849980
[TBL] [Abstract][Full Text] [Related]
6. Immunization against foot-and-mouth disease with synthetic peptides representing the C-terminal region of VP1.
Doel TR; Gale C; Brooke G; DiMarchi R
J Gen Virol; 1988 Sep; 69 ( Pt 9)():2403-6. PubMed ID: 2457649
[TBL] [Abstract][Full Text] [Related]
7. Antibody response to 146S particle, 12S protein subunit and isolated VP1 polypeptide of foot-and-mouth disease virus type Asia-1.
Rao MG; Butchaiah G; Sen AK
Vet Microbiol; 1994 Mar; 39(1-2):135-43. PubMed ID: 8203119
[TBL] [Abstract][Full Text] [Related]
8. Immunological evaluation of the multiple antigen peptide (MAP) system using the major immunogenic site of foot-and-mouth disease virus.
Francis MJ; Hastings GZ; Brown F; McDermed J; Lu YA; Tam JP
Immunology; 1991 Jul; 73(3):249-54. PubMed ID: 1652552
[TBL] [Abstract][Full Text] [Related]
9. Liposome encapsulated subunit (VP1) and virion vaccines against foot-and-mouth disease.
Vasantha S; Antony A; Lal SM
Acta Virol; 1987 Mar; 31(2):109-15. PubMed ID: 2886019
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of fusion proteins with multiple copies of an antigenic determinant of foot-and-mouth disease virus.
Broekhuijsen MP; Blom T; van Rijn J; Pouwels PH; Klasen EA; Fasbender MJ; Enger-Valk BE
Gene; 1986; 49(2):189-97. PubMed ID: 2436976
[TBL] [Abstract][Full Text] [Related]
11. Development of replication-defective adenovirus serotype 5 containing the capsid and 3C protease coding regions of foot-and-mouth disease virus as a vaccine candidate.
Mayr GA; Chinsangaram J; Grubman MJ
Virology; 1999 Oct; 263(2):496-506. PubMed ID: 10544121
[TBL] [Abstract][Full Text] [Related]
12. Use of peptides for immunization against foot-and-mouth disease.
Brown F
Vaccine; 1988 Apr; 6(2):180-2. PubMed ID: 2838987
[TBL] [Abstract][Full Text] [Related]
13. [Protection from foot-and-mouth disease virus in naturally-susceptible animals by a linear polymer of a synthetic peptide].
Pavlov AV; Rybakov SS; Ivaniushchenkov VN; Chepurkin AV; Petrov VN; Driagalin NN; Burdov AN
Bioorg Khim; 1991 Jul; 17(7):953-63. PubMed ID: 1665331
[TBL] [Abstract][Full Text] [Related]
14. Characterization and immune response of a protein produced by a cDNA clone of foot and mouth disease virus, type Asia 1 63/72.
Suryanarayana VV; Venkataramanan R; Rao BU; Padayatty JD
Biochem Int; 1992 May; 26(6):1003-16. PubMed ID: 1378734
[TBL] [Abstract][Full Text] [Related]
15. Bacterially expressed antigenic peptide from foot-and-mouth disease virus capsid elicits variable immunologic responses in animals.
Winther MD; Allen G; Bomford RH; Brown F
J Immunol; 1986 Mar; 136(5):1835-40. PubMed ID: 3005401
[TBL] [Abstract][Full Text] [Related]
16. [Antigenic structure of the foot-and-mouth-disease virus. I. Synthesis of protective peptides from the major immunogenic region of VP1 protein of foot-and-mouth virus type O1K].
Surovoĭ AIu; Vol'pina OM; Snetkova EV; Volkova TD; Ivanov VT
Bioorg Khim; 1988 Oct; 14(10):1352-62. PubMed ID: 2852937
[TBL] [Abstract][Full Text] [Related]
17. Serological prospects for peptide vaccines against foot-and-mouth disease virus.
Parry NR; Ouldridge EJ; Barnett PV; Clarke BE; Francis MJ; Fox JD; Rowlands DJ; Brown F
J Gen Virol; 1989 Nov; 70 ( Pt 11)():2919-30. PubMed ID: 2479714
[TBL] [Abstract][Full Text] [Related]
18. A DNA vaccine encoding foot-and-mouth disease virus B and T-cell epitopes targeted to class II swine leukocyte antigens protects pigs against viral challenge.
Borrego B; Argilaguet JM; Pérez-Martín E; Dominguez J; Pérez-Filgueira M; Escribano JM; Sobrino F; Rodriguez F
Antiviral Res; 2011 Nov; 92(2):359-63. PubMed ID: 21820470
[TBL] [Abstract][Full Text] [Related]
19. Enhanced immunogenicity of multiple-epitopes of foot-and-mouth disease virus fused with porcine interferon alpha in mice and protective efficacy in guinea pigs and swine.
Du Y; Li Y; He H; Qi J; Jiang W; Wang X; Tang B; Cao J; Wang X; Jiang P
J Virol Methods; 2008 Apr; 149(1):144-52. PubMed ID: 18294705
[TBL] [Abstract][Full Text] [Related]
20. Improved immunogenicity of a peptide epitope after fusion to hepatitis B core protein.
Clarke BE; Newton SE; Carroll AR; Francis MJ; Appleyard G; Syred AD; Highfield PE; Rowlands DJ; Brown F
Nature; 1987 Nov 26-Dec 2; 330(6146):381-4. PubMed ID: 2446137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
